Optimizing type 2 diabetes treatment goes beyond A1C goals to addressing cardiovascular and kidney disease. This presentation highlights pharmacists' roles in guideline-driven care and patient education, emphasizing the importance of teamwork and holistic treatment approaches for long-term outcomes.

• Examine team-based strategies for reducing complications of type 2 diabetes and associated comorbidities
• Evaluate multitarget pharmacotherapy approaches for type 2 diabetes, cardiovascular disease, heart failure, obesity, and kidney disease
• Apply guidelines to patient-specific scenarios for optimizing therapy and reducing complications

Level: Intermediate